Investors Inject $125.5M Into Early Cancer Detection Co.
China-based Burning Rock Biotech, which develops products for early cancer detection, has received a capital injection of RMB 850 million ($125.5 million) from a group of private investors led by Singapore...To view the full article, register now.
Already a subscriber? Click here to view full article